These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

875 related items for PubMed ID: 16394033

  • 21. Fetal heart rate in chromosomally abnormal fetuses.
    Liao AW, Snijders R, Geerts L, Spencer K, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2000 Dec; 16(7):610-3. PubMed ID: 11169365
    [Abstract] [Full Text] [Related]

  • 22. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W, Wong AE, Dezerega V.
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [Abstract] [Full Text] [Related]

  • 23. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy.
    Brizot ML, Snijders RJ, Bersinger NA, Kuhn P, Nicolaides KH.
    Obstet Gynecol; 1994 Dec; 84(6):918-22. PubMed ID: 7526305
    [Abstract] [Full Text] [Related]

  • 24. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
    von Kaisenberg CS, Gasiorek-Wiens A, Bielicki M, Bahlmann F, Meyberg H, Kossakiewicz A, Pruggmayer M, Kamin G, Fritzer E, Harris C, Arnold N, German Speaking Down Syndrome Screening Group.
    J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
    [Abstract] [Full Text] [Related]

  • 25. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan.
    Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2005 Jul; 26(1):22-7. PubMed ID: 15937972
    [Abstract] [Full Text] [Related]

  • 26. Nuchal translucency thickness and crown-rump length in twin pregnancies with chromosomally abnormal fetuses.
    Pandya PP, Hilbert F, Snijders RJ, Nicolaides KH.
    J Ultrasound Med; 1995 Aug; 14(8):565-8. PubMed ID: 7474052
    [Abstract] [Full Text] [Related]

  • 27. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P, Sonek J, Hoopmann M, Abele H, Kagan KO.
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [Abstract] [Full Text] [Related]

  • 28. Megacystis at 10-14 weeks of gestation: chromosomal defects and outcome according to bladder length.
    Liao AW, Sebire NJ, Geerts L, Cicero S, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):338-41. PubMed ID: 12704740
    [Abstract] [Full Text] [Related]

  • 29. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
    Papageorghiou AT, Avgidou K, Spencer K, Nix B, Nicolaides KH.
    Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
    [Abstract] [Full Text] [Related]

  • 30. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S, Spencer K, Avgidou K, Faiola S, Nicolaides KH.
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [Abstract] [Full Text] [Related]

  • 31. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
    Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJ, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
    [Abstract] [Full Text] [Related]

  • 32. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP, Snijders RJ, Johnson S, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [Abstract] [Full Text] [Related]

  • 33. Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency.
    Sebire NJ, Noble PL, Psarra A, Papapanagiotou G, Nicolaides KH.
    Br J Obstet Gynaecol; 1996 Sep; 103(9):887-90. PubMed ID: 8813308
    [Abstract] [Full Text] [Related]

  • 34. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects.
    Cicero S, Longo D, Rembouskos G, Sacchini C, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2003 Jul; 22(1):31-5. PubMed ID: 12858299
    [Abstract] [Full Text] [Related]

  • 35. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E, van Lith JM, Mol BW, Bleker OP, Bilardo CM.
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [Abstract] [Full Text] [Related]

  • 36. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A, Grunewald C, Saltvedt S, Valentin L, Almström H.
    Acta Obstet Gynecol Scand; 2006 Sep; 85(5):534-8. PubMed ID: 16752230
    [Abstract] [Full Text] [Related]

  • 37. Screening for fetal chromosomal abnormalities with nuchal translucency measurement in the first trimester.
    Has R, Kalelioglu I, Ermis H, Ibrahimoglu L, Yuksel A, Yildirim A, Basaran S.
    Fetal Diagn Ther; 2006 Sep; 21(4):355-9. PubMed ID: 16757911
    [Abstract] [Full Text] [Related]

  • 38. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G, Graesslin O, Alanio E, Bige V, Gaillard D, Gabriel R.
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [Abstract] [Full Text] [Related]

  • 39. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N, Egić A, Filimonović D, Marinković M, Damnjanović-Pazin B, Milovanović Z, Joksić I, Branković S, Lukić R, Mandić V, Cerović N, Mojović D, Plamenac S, Stanković M, Maglić D, Mikovć Z.
    Srp Arh Celok Lek; 2012 Oct; 140(9-10):606-11. PubMed ID: 23289277
    [Abstract] [Full Text] [Related]

  • 40. Predictive value of increased nuchal translucency as a screening test for the detection of fetal chromosomal abnormalities.
    Alexioy E, Alexioy E, Trakakis E, Kassanos D, Farmakidis G, Kondylios A, Laggas D, Salamalekis E, Florentin L, Kanavakis E, Basios G, Trompoukis P, Georgiadoy L, Panagiotopoulos T.
    J Matern Fetal Neonatal Med; 2009 Oct; 22(10):857-62. PubMed ID: 19521928
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.